Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.

Basak Oyan; Ozlem Sonmez; Aziz Yazar; Mehmet Teomete

doi:10.1200/jco.2018.36.15_suppl.e24306

Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e24306 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e24306-e24306 ◽

Cited By ~ 1

Author(s):

Basak Oyan ◽

Ozlem Sonmez ◽

Aziz Yazar ◽

Mehmet Teomete

Keyword(s):

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Metastatic Cancer

Download Full-text

The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.09.010 ◽

2019 ◽

Vol 103 (1) ◽

pp. 142-151 ◽

Cited By ~ 36

Author(s):

Luke R.G. Pike ◽

Andrew Bang ◽

Brandon A. Mahal ◽

Allison Taylor ◽

Monica Krishnan ◽

...

Keyword(s):

Radiation Therapy ◽

Cancer Patients ◽

Immune Checkpoint ◽

Lymphocyte Count ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Metastatic Cancer ◽

The Impact

Download Full-text

302MO Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors

Annals of Oncology ◽

10.1016/j.annonc.2020.10.296 ◽

2020 ◽

Vol 31 ◽

pp. S1360

Author(s):

J-G. Zhou ◽

A.J. Donaubauer ◽

B. Frey ◽

I. Becker ◽

S. Rutzner ◽

...

Keyword(s):

Flow Cytometry ◽

Cancer Patients ◽

Immune Checkpoint ◽

Whole Blood ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Metastatic Cancer ◽

Immune Signature

Download Full-text

Impact of CT-based body composition parameters at baseline, their early changes and response in metastatic cancer patients treated with immune checkpoint inhibitors

European Journal of Radiology ◽

10.1016/j.ejrad.2020.109340 ◽

2020 ◽

Vol 133 ◽

pp. 109340

Author(s):

Amandine Crombé ◽

Michèle Kind ◽

Maud Toulmonde ◽

Antoine Italiano ◽

Sophie Cousin

Keyword(s):

Body Composition ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Metastatic Cancer

Download Full-text

Dosimetric Modeling of Lymphopenia in Metastatic Cancer Patients Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors

Advances in Radiation Oncology ◽

10.1016/j.adro.2021.100880 ◽

2021 ◽

pp. 100880

Author(s):

Jack Qian ◽

Elliot Akama-Garren ◽

Jungwook Shin ◽

Lauren Gunasti ◽

Andrew Bang ◽

...

Keyword(s):

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Metastatic Cancer ◽

Palliative Radiation

Download Full-text

STK11 Gene Mutation is a Negative Prognostic Predictor for Metastatic Cancer Patients Treated with Immune Checkpoint Inhibitors

Saudi Journal of Medical and Pharmaceutical Sciences ◽

10.36348/sjmps.2019.v05i12.002 ◽

2019 ◽

Vol 05 (12) ◽

pp. 1029-1033

Author(s):

Yongping Liu ◽

lin Chen ◽

ShenLi Zhang ◽

Qiufeng Qi ◽

Ming Zhu ◽

...

Keyword(s):

Cancer Patients ◽

Gene Mutation ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Metastatic Cancer ◽

Stk11 Gene ◽

Prognostic Predictor

Download Full-text

Abstract 382: Longitudinal C-reactive protein (CRP) as an individualized dynamic predictor for metastatic cancer patients treated with immune checkpoint inhibitors: Findings from the prospective ST-ICI cohort

10.1158/1538-7445.am2021-382 ◽

2021 ◽

Author(s):

Jian-Guo Zhou ◽

Hu Ma ◽

Udo Gaipl ◽

Benjamin Frey ◽

Markus Hecht ◽

...

Keyword(s):

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Metastatic Cancer ◽

C Reactive Protein ◽

Reactive Protein

Download Full-text

Abstract #582 Endocrine Consequences of Combination Therapy of Immune Checkpoint Inhibitors in Cancer Patients

Endocrine Practice ◽

10.1016/s1530-891x(20)46926-5 ◽

2019 ◽

Vol 25 ◽

pp. 297-298

Author(s):

Sevil Aliyeva ◽

Pamela Schroeder ◽

Issam Cheikh

Keyword(s):

Combination Therapy ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors

Download Full-text

Faculty Opinions recommendation of Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727096591.793526264 ◽

2016 ◽

Author(s):

Mariya Miteva

Keyword(s):

Cancer Patients ◽

Alopecia Areata ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors

Download Full-text

50P Update of systematic reviews and meta-analyses studying the association between antibiotic use and clinical outcomes of cancer patients treated with immune checkpoint inhibitors

Annals of Oncology ◽

10.1016/j.annonc.2020.10.537 ◽

2020 ◽

Vol 31 ◽

pp. S1436

Author(s):

G. Zalcman ◽

A. Crespin ◽

J. Cervesi ◽

C. Le Bescop ◽

R. Buffet ◽

...

Keyword(s):

Cancer Patients ◽

Clinical Outcomes ◽

Systematic Reviews ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Antibiotic Use ◽

Meta Analyses

Download Full-text

Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Cancer Immunology Immunotherapy ◽

10.1007/s00262-020-02783-6 ◽

2021 ◽

Author(s):

Shinkichi Takamori ◽

Kazuki Takada ◽

Mototsugu Shimokawa ◽

Mikako Jinnnouchi ◽

Taichi Matsubara ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Prognostic Impact ◽

Primary Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text